✦ LIBER ✦

Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

✍ Scribed by C. Verkindre; Y. Fukuchi; A. Flémale; A. Takeda; T. Overend; N. Prasad; M. Dolker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bronchodilatory effects of NVA237, a onc

✍ Charles Fogarty; Helen Hattersley; Lilla Di Scala; Anton Drollmann 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Safety and tolerability of NVA237, a onc

✍ C. Vogelmeier; C. Verkindre; D. Cheung; J.B. Galdiz; S.Z. Güçlü; S. Spangenthal; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 457 KB

Efficacy and safety of the long-acting m

✍ Eric Bateman; Gregory Feldman; Sally Kilbride; Jean Brooks; Rashmi Mehta; Stepha 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 546 KB

Bronchodilation of umeclidinium, a new l

✍ Decramer, Marc; Maltais, François; Feldman, Gregory; Brooks, Jean; Harris, Steph 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 643 KB

A blinded evaluation of the efficacy and

✍ Chapman, Kenneth R; Beeh, Kai-Michael; Beier, Jutta; Bateman, Eric D; D’Urzo, An 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 225 KB

Bronchodilatory effects of aclidinium br

✍ G.F. Joos; V.J. Schelfhout; R.A. Pauwels; F. Kanniess; H. Magnussen; R. Lamarca; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 237 KB